SUNSET: SBRT for Ultra-central NSCLC- a Safety and Efficacy Trial | MicrobiomeTrials← Back to trialsNCT03306680
SUNSET: SBRT for Ultra-central NSCLC- a Safety and Efficacy Trial
RecruitingPHASE1INTERVENTIONAL
Trial Details
Start: 2018-01-19Est. Completion: 2021-04-19
Enrollment target: 30 participants Locations- BC Cancer -Vancouver Island, Vancouver, British Columbia, Canada
- London Regional Cancer Program, London, Ontario, Canada
- Sunnybrook Odette Cancer Centre, Toronto, Ontario, Canada
- Princess Margaret Cancer Centre, Toronto, Ontario, Canada
- Centre Hospitalier de l'Universite de Montreal (CHUM), Montreal, Quebec, Canada
- McGill University Health Centre-Cedars Cancer Centre, Montreal, Quebec, Canada
- Saskatoon Cancer Centre, Saskatoon, Saskatchewan, Canada
Other microbiome trials you might be interested in
Chronic Graft Versus Host DiseaseHematopoietic and Lymphatic System NeoplasmMalignant Solid Neoplasm
This clinical trial tests a mindfulness intervention, consisting of group sessions and an individual session, using mind…
Duarte, United StatesEst. completion Mar 1, 2029
Pancreatic Ductal AdenocarcinomaNon-small Cell Lung CancerHR+/HER2- Ductal and Lobular Breast CancerTriple Negative Breast CancerColorectal Cancer
The purpose of this study is to evaluate the safety, tolerability, dosimetry and preliminary efficacy of \[177Lu\]Lu-NNS…
Birmingham, United StatesEst. completion Jan 15, 2031
MelanomaGliomaThyroid CancerNon-Small Cell Lung CancerMalignant NeoplasmsBrain NeoplasmsAdvanced or Metastatic Solid TumorsHGGLGGLow Grade GliomaHigh Grade GliomaDifferentiated Thyroid CancerNSCLC (Non-small Cell Lung Cancer)
The purpose of this clinical trial is to learn the safety and effects of the study medicine (PF-07799544) alone or in co…
Birmingham, United StatesEst. completion Aug 2, 2027